SC
Stempoint Capital Portfolio holdings
AUM
$311M
1-Year Return
15.22%
This Quarter Return
-10.5%
1 Year Return
+15.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$313M
AUM Growth
-$85.6M
(-21%)
Cap. Flow
-$51.2M
Cap. Flow
% of AUM
-16.34%
Top 10 Holdings %
Top 10 Hldgs %
50.65%
Holding
79
New
24
Increased
12
Reduced
14
Closed
20
Top Buys
| 1 |
Arcellx
ACLX
|
$18M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$13.6M |
| 3 |
Scholar Rock
SRRK
|
$12.9M |
| 4 |
BridgeBio Pharma
BBIO
|
$7.21M |
| 5 |
CG Oncology
CGON
|
$7.1M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$16.2M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$15.7M |
| 3 |
Incyte
INCY
|
$13.4M |
| 4 |
Merus
MRUS
|
$11.3M |
| 5 |
Praxis Precision Medicines
PRAX
|
$10.3M |
Sector Composition
| 1 | Healthcare | 99.51% |
| 2 | Financials | 0.49% |
| 3 | Consumer Staples | 0% |